云南白药集团股份有限公司发布2015年3季度报告,其第3季度营收超过50亿元。报告显示,云南白药第3季度营收51.45亿元,同比增长9.7%;营业利润10.14亿元,同比增长8.8%;归属于上市公司股东的净利润8.87亿元,同比增长8.89%。合并看来,云南白药前3季度共营收146.88亿元,同比增长10.29%;营业利润24.53亿元,同比增长10%;归属于上市公司股东的净利润21.42亿元,同 Yunnan Baiyao Group Co., Ltd. released its 2015 third quarterly report. Its revenue in the third quarter was over 5 billion yuan. The report shows that Yunnanbaiyao third quarter revenue of 5.145 billion yuan, an increase of 9.7%; operating profit of 1.014 billion yuan, an increase of 8.8%; attributable to shareholders of listed companies net profit of 887 million yuan, an increase of 8.89%. Merger, Yunnanbaiyao the first three quarters of a total revenue of 14.688 billion yuan, an increase of 10.29%; operating profit of 2.453 billion yuan, an increase of 10%; attributable to shareholders of listed companies net profit of 2.142 billion yuan, with